Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Huang, Hsiao Chun ^a   Mitchison, Timothy J ^a   Shi, Jue ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CELL CYCLE PROTEIN 20; CYCLIN B1; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CDC20 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYSTEINE PROTEINASE INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; SMALL INTERFERING RNA;

ARTICLE; BIOCHEMISTRY; CELL DEATH; CELL FATE; CELL FUNCTION; CELL KINETICS; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PROTEIN DEGRADATION; TIME LAPSE IMAGING; CELL LINEAGE; CHEMISTRY; GENETIC TRANSCRIPTION; HELA CELL; KINETICS; METABOLISM; MITOSIS; STATISTICS; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; CELL LINEAGE; CYCLIN B1; CYSTEINE PROTEINASE INHIBITORS; HELA CELLS; HUMANS; KINETICS; MITOSIS; RNA, SMALL INTERFERING; STOCHASTIC PROCESSES; TRANSCRIPTION, GENETIC;

EID: 78650992174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015724     Document Type: Article

References (26)

1. Maamar H, Raj A, Dubnau D (2007) Noise in gene expression determines cell fate in Bacillus subtilis. Science 317: 526-529.
2. Kussell E, Leibler S (2005) Phenotypic diversity, population growth, and information in fluctuating environments. Science 309: 2075-2078.
3. Warren L, Bryder D, Weissman IL, Quake SR (2006) Transcription factor profiling in individual hematopoietic progenitors by digital RT-PCR. Proc Natl Acad Sci USA 103: 17807-17812.
4. Jackson JR, Patrick DR, Dar MM, Huang PS (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7: 107-117.
5. Rieder CL, Maiato H (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7: 637-651.
6. Shi J, Orth JD, Mitchison T (2008) Cell type variation in responses to antimitotic drugs that target microtubules and kinesin-5. Cancer Res 68: 3269-3276.
7. Gascoigne KE, Taylor SS (2008) Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14: 111-122.
8. Orth JD, Tang Y, Shi J, Loy CT, Amendt C, et al. (2008) Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol Cancer Ther 7: 3480-3489.
9. Huang HC, Shi J, Orth JD, Mitchison TJ (2009) Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16: 347-358.
10. Blagosklonny MV, Demidenko ZN, Giovino M, Szynal C, Donskoy E, et al. (2006) Cytostatic activity of paclitaxel in coronary artery smooth muscle cells is mediated through transient mitotic arrest followed by permanent post-mitotic arrest: comparison with cancer cells. Cell Cycle 5(14): 1574-1579.
11. Demidenko ZN, Kalurupalle S, Hanko C, Lim CU, Broude E, et al. (2008) Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 27(32): 4402-4410.
12. Blagosklonny MV, Robey R, Sheikh MS, Fojo T (2002) Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death. Cancer Biol Ther 1(2): 113-117.
13. Blagosklonny MV (2007) Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 6(1): 70-74.
14. Brito DA, Rieder CL (2006) Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 16: 1194-1200.
15. Wang LG, Liu XM, Kreis W, Budman DR (1999) The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355-361.
16. Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, et al. (2004) Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279: 51057-51067.
17. Tao W, South VJ, Zhang Y, Davide JP, Farrell L, et al. (2005) Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 8: 49-59.
18. Albeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, et al. (2008) Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol Cell 30: 11-25.
19. Kim M, Murphy K, Liu F, Parker SE, Dowling ML, et al. (2005) Caspasemediated specific cleavage of BubR1 is a determinant of mitotic progression. Mol Cell Biol 25: 9232-9248.
20. Allan LA, Clarke PR (2007) Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 26: 301-310.
21. Johnstone RW, Frew AJ, Smyth MJ (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8: 782-798.
22. Bentley AM, Normand G, Hoyt J, King RW (2007) Distinct sequence elements of cyclin B1 promote localization to chromatin, centrosomes, and kinetochores during mitosis. Mol Biol Cell 18: 4847-4858.
23. Noguchi S (2006) Predictive factors for response to docetaxel in human breast cancers. Cancer Sci 97: 813-820.
24. Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, et al. (2008) Dynamic proteomics of individual cancer cells in response to a drug. Science 322: 1511-1516.
25. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK (2009) Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459: 428-432.
26. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM (2002) Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 51: 133-140.